Seizures in the adult intensive care unit

Journal of Neurosurgical Anesthesiology

Volumn 13, Issue 2, 2001, Pages 163-175

  Varelas, Panayiotis N ^a   Mirski, Marek A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Anticonvulsants; Intensive care unit; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; FELBAMATE; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; MIDAZOLAM; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

BRAIN HYPOXIA; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; HUMAN; INTENSIVE CARE; LIVER TOXICITY; METABOLIC DISORDER; NEUROSURGERY; PATHOGENESIS; PHLEBITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SEIZURE; TREATMENT INDICATION;

HUMANS; INTENSIVE CARE UNITS; SEIZURES;

EID: 0035087016     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-200104000-00016     Document Type: Review

References (127)

1. Epidemiology and the genetics of epilepsy
2. Neurologic complications of critical medical illness
3. Status epilepticus: Concepts in diagnosis and treatment
4. Determinants of mortality in status epilepticus
5. Status epilepticus
6. Status epilepticus-induced neuronal injury and network reorganization
7. Predictive factors of early seizures after acute cerebrovascular disease
8. Population-based study of seizure disorders alter cerebral infarction
9. The course of seizure disorders in patients with malignant gliomas
10. Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: A meta-analysis
11. New-onset seizures in critically ill patients
12. Herpes simplex virus infections of the central nervous system: Therapeutic and diagnostic considerations
13. A population-based study of seizures after traumatic brain injuries
14. Early seizures after severe closed head injury
15. Early seizures after moderate closed head injury
16. A randomized, double-blind study of phenytoin for the prevention of posttraumatic seizures
17. Risk of seizure recurrence after the first late posttraumatic seizure
18. Clinical hypoxia: Causes, consequences, and correction
19. Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies
20. Drugs that can precipitate seizures
21. Antibiotic-induced convulsions
22. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastatin
23. The safety profile of imipenem/cilatatin: Worldwide clinical experience based on 3470 patients
24. Neurotoxicity of carbapenem antimicrobials
25. Structural features resulting in convulsive activity of carbapenem compounds: Effect of C-2 side chain
26. Seizures associated with antidepressants: A review
27. Seizures with neuroleptics and antidepressants
28. Antipsychotic drugs and seizures
29. Life-threatening theophylline toxicity is not predictable by serum levels
30. Hospital admission for xanthine toxicity
31. Seizure after lidocaine for bronchoscopy: Case report and review of the use of lidocaine in airway anesthesia
32. Complications of fiberoptic bronchoscopy
33. Seizures induced by oral viscous lidocaine
34. Lidocaine toxicity from topical mucosal application. With a review of the clinical pharmacology of lidocaine
35. Seizures following oral lidocaine for esophageal anesthesia
36. Prolonged seizures associated with the use of viscous lidocaine
37. Seizures and antiepileptic drug use in transplant patients
38. Neonatal seizures associated with narcotic withdrawal
39. Pro- and anticonvulsant actions of morphine and the endogenous opioids: Involvement and interactions of multiple opiate and non-opiate systems
40. Intracranial lesions shown by CT scans in 259 cases of first alcohol-related seizures
41. Seizure and acute osmotic change: Clinical and neurophysiological aspects
42. Glucose concentration inversely alters neocortical slice excitability through an osmotic effect
43. Changes in the activity of glutamate related enzymes in cerebral cortex, during insulin-induced seizures
44. Neurologic complications of renal disease
45. Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy
46. The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation
47. Comprehensive drug surveillance
48. Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms
49. Mechanisms of action of convulsants
50. Effect of penicillin on GABA-gated chloride ion influx
51. Dual mechanisms of GABAA response inhibition by beta-lactam antibiotics in the pyramidal neurones of the rat cerebral cortex
52. Pro- and anticonvulsant effects of anesthetics (Part I)
53. Pro- and anticonvulsant effects of anesthetics (Part II)
54. Anesthetic implications of epilepsy, status epilepticus, and epilepsy surgery
55. Enflurane-induced grand mal seizures during otic microsurgery
56. Status epilepticus following enflurane anaesthesia
57. Effect of etomidate on the electroencephalogram of patients with epilepsy
58. General anesthesia in patients with epilepsy and status epilepticus
59. Early postoperative seizures in neurosurgical patients administered atracurium and isoflurane
60. Opioid-induced epileptogenic phenomena: Anatomical, behavioral, and electroencephalographic features
61. Fentanyl-induced electrocorticographic seizures in patients with complex partial epilepsy
62. Normeperidine toxicity
63. Prevalence of nonconvulsive status epilepticus in comatose patients
64. Continuous EEG monitoring in the neuroscience intensive care unit and emergency department
65. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus
66. A comparison of four treatments for generalized convulsive status epilepticus
67. Parenteral antiepileptic/anticonvulsant drugs
68. Sedation for the critically ill neurologic patient
69. Intravenous anaesthetic agents. Pharmaco-kinetic-pharmacodynamic relationships
70. Midazolam kinetics
71. Dose-sependent effects of intravenous lorazepam on cardiovascular activity, plasma catecholamines and psychological function during rest and mental stress
72. Pharmacology and pharmacokinetics of fosphenytoin
73. Alterations in the carnitine metabolism in epileptic children treated with valproic acid
74. Standard antiepileptic drugs. Contemporary diagnosis and management of the patient with epilepsy
75. New antiepileptic drugs: Basic science and clinical use in children and adults
76. The role of new antiepileptic drugs
77. Patients with refractory seizures
78. Could lamotrigine be useful in status epilepticus? A case report
79. Lamotrigine vs. phenytoin for treatment of status epilepticus: Comparison in an experimental model
80. Two cases of nonconvulsive status epilepticus in association with tiagabine therapy
81. Status epilepticus during vigabatrin treatment: A report of three cases
82. New antiepileptic drugs: Comparison of key clinical trials
83. Clinical experience with new antiepileptic drugs: Antiepileptic drugs in Europe
84. Monostars: An aid to choosing an antiepileptic drug as monotherapy
85. The clinical pharmacokinetics of the new antiepileptic drugs
86. Pathophysiology of status epilepticus
87. Very high dose phenobarbital for refractory status epilepticus in chidren
88. Prolonged low flow isoflurane anesthesia for status epilepticus
89. Intravenous midazolam for the treatment of refractory status epilepticus
90. Barbiturate anesthesia in the treatment of status epilepticus: Clinical experience with 14 patients
91. Propofol infusion for control of status epilepticus
92. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus
93. Rapid treatment of status epilepticus with low dose pentobarbital
94. Hypothermia and barbiturate coma for refractory status epilepticus
95. Comparison of isoflurane, halothane, and nitrous oxide in status epilepticus
96. Propofol and seizures
97. Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings
98. Predicting outcome from hypoxic-ischemic coma
99. Prediction of awakening after out-of-hospital cardiac arrest
100. Value of a revised EEG coma scale for prognosis after cerebral anoxia and diffuse head injury
101. Prognostic value of early cortical somatosensory evoked potentials after resuscitation from cardiac arrest
102. Populations at risk for penicillin-induced seizures
103. Predisposing factors to apparent theophylline-induced seizures
104. Theophylline overdose: Acute single ingestion versus chronic repeated overmedication
105. Enhancement of theophylline clearance by oral activated charcoal
106. Massive theophylline overdose: Rapid elimination by charcoal hemoperfusion
107. Role of dialysis in the management and prevention of theophylline toxicity
108. Single high-dose pyridoxine treatment for isoniazid overdose
109. Toxic effects of drugs used in the ICU. Anticonvulsant agents
110. Altering drug dose in patients with diseases of kidney and liver
111. The drug treatment of epilepsy
112. Antiepileptic medication interactions
113. Cimetidine-phenytoin interaction: Effect on serum phenytoin concentration and antipyrine test
114. Effect of over-the-counter cimetidine on phenytoin concentrations in patients with seizures
115. Hepatic toxicity of antiepileptic drugs
116. Cytochrome P-450-catalyzed formation of delta-4-VPA, a toxic metabolite of valproic acid
117. Status epilepticus in stroke: Report on a hospital-based stroke cohort
118. Guidelines for the management of patients with acute ischemic stroke. A statement for health care professionals from a special writing group of the stroke council, American heart association
119. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for health care professionals from a special writing group of the stroke council, American heart association
120. Postoperative prophylactic anticonvulsant therapy in cerebral gliomas
121. Posttraumatic seizure prevention - Results of a survey of 127 neurosurgery clinics
122. Chronic subdural hematomas and seizures: The role of prophylactic anticonvulsive medication
123. The incidence of postoperative seizures
124. Phenytoin and postoperative epilepsy. A double-blind study
125. Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: Efficacy, tolerability, and cognitive effects
126. Anticonvulsant prophylaxis in neurological surgery